SEARCH

SEARCH BY CITATION

References

  • 1
    Williams DN. Home intravenous antibiotic therapy (HIVAT): indications, patients and antimicrobial agents. Int J Antimicrob Agents 1995; 5: 3 8.DOI: 10.1016/0924-8579(94)00046-w
  • 2
    Graninger W, Prester E, Wenisch C, Schwameiss E, Breyer S, Vukovich T. Management of serious staphylococcal infections in the outpatient setting. Drugs 1997; 54(suppl 6): 21 8.
  • 3
    Nathwani D & Davey P. Intravenous antimicrobial therapy in the community: underused, inadequately resourced, or irrelevant to health care in Britain? Br Med J 1996; 313: 1541 3.
  • 4
    Wiselka MJ & Nicholson KG. Outpatient parenteral antimicrobial therapy: experience in a large teaching hospital. J Infect 1997; 35: 73 6.
  • 5
    Kayley J, Berendt AR, Snelling MJM et al. Safe intravenous antibiotic therapy at home: experience of a UK based programme. J Antimicrob Chemother 1996; 37: 1023 30.
  • 6
    Wijlhuizen TJ, Haaren CPLC, Vermeij P, Broek VD. Indications for home intravenous therapy in the Netherlands. Int J Antimicrob Agents 1995; 5: 55 8.DOI: 10.1016/0924-8579(94)00047-x
  • 7
    Smerund KT & Kalager T. Outpatient intravenous antibiotic treatment in Norway: experiences, expectations, and research [abstract 5]. In: Outpatient Intravenous Infusion Therapy Association Conference, Chicago. Chicago, 1994: 20 1.
  • 8
    Kibbler CC & Prentice HG. Which febrile neutropenic patients are suitable for outpatient management? Current Opin Infect Dis 1997; 10: 251 4.
  • 9
    Winter RJ, George RJ, Deacock SJ, Shee CD, Geddes DM. Self-administered home intravenous antibiotic therapy in bronchiectasis and adult cystic fibrosis. Lancet 1984; 161: 1338 9.
  • 10
    Nathwani D, Morrison J, Gray K, Seaton RA, France AJ, Davey P. Outpatient and home parenteral antibiotic therapy (OHPAT): evaluation of the impact of one year's experience in Tayside. Health Bull 1999; 57: 332 7.
  • 11
    Nathwani D & Conlon C. Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party. Clin Microbiol Infect 1998; 4: 537 51.
  • 12
    Hoffman-Terry ML, Fraimow HS, Fox TR, Swift BG, Wolf JE. Adverse effects of outpatient parenteral antibiotic therapy. Am J Med 1999; 106: 44 9.DOI: 10.1016/s0002-9343(98)00362-3
  • 13
    Williams DN, Rehm SJ, Tice AD, Bradely JS, Kind AC, Craig WA. Practice guidelines for community-based parenteral anti-infective therapy. Clin Infect Dis 1997; 25: 787 801.
  • 14
    Seaton RA, Nathwani D, Williams FLR, Boyter AC. Feasibility of an outpatient and home parenteral antibiotic therapy (OHPAT) programme in Tayside. Scotland J Infect 1999; 39: 129 33.
  • 15
    Parker S, Nathwani D, O'Reilly D, Parkinson S, Davey P. Evaluation of the impact of non-inpatient iv antibiotic treatment for acute infections on the hospital, primary care services and the patient. J Antimicrob Chemother 1998; 42: 373 80.
  • 16
    Seaton RA, Morrison J, Man I, Watson J, Nathwani D. Outpatient parenteral antimicrobial therapy—a viable option for the management of cutaneous leishmaniasis. Q J Med 1999; 92: 659 67.
  • 17
    NHS Management Executive. Purchasing high-tech health care for patients at home (EL (95) 5). Leeds: NHSME, 1995.